Nuovi farmaci per il trattamento dell’Epatite C
Review article: investigational agents for chronic hepatitis C.Thompson AJ, McHutchison JG. Aliment Pharmacol Ther. 2009 Jan 17. [Epub ahead of…
Approfondisci...
Impatto della dieta sulla fibrosi epatica e sulla risposta all’IFN
The impact of diet on liver fibrosis and on response to interferon therapy in patients with HCV-related chronic hepatitis.Loguercio C,…
Epatite tossica da diclofenac….
How common is diclofenac-associated liver injury? Analysis of 17,289 arthritis patients in a long-term prospective clinical trial.Laine L, Goldkind L,…
RCT: La sinvastatina riduce la pressione portale …..
SIMVASTATIN LOWERS PORTAL PRESSURE IN PATIENTS WITH CIRRHOSIS AND PORTAL HYPERTENSION: A RANDOMIZED CONTROLLED TRIAL.Abraldes J, Albillos A, Bañares R,…
Rischio di cancro della via biliare e del pancreas in HCV+
Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans.El-Serag HB, Engels EA,…
Cirrosi alcolica meglio subito in lista trapianto o la standard care?
Immediate listing for liver transplantation versus standard care for Child-Pugh stage B alcoholic cirrhosis: a randomized trial.Vanlemmens C, Di Martino…
Tenofovir vs adefovir nell’epatite cronica B
Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.Marcellin P, Heathcote EJ, Buti M, Gane E, de Man RA,…
RF vs PEI nel piccolo HCC: una meta-analisi
Radiofrequency Thermal Ablation vs. Percutaneous Ethanol Injection for Small Hepatocellular Carcinoma in Cirrhosis: Meta-Analysis of Randomized Controlled Trials.Orlando A, Leandro…
L’etnia può condizionare la risposta all’interferone
Peginterferon alfa-2a and ribavirin in Latino and non-Latino whites with hepatitis C.Rodriguez-Torres M, Jeffers LJ, Sheikh MY, Rossaro L, Ankoma-Sey…
La variazione genica predice la risposta alla terapia nell’infezione da virus C
Genome-wide hepatitis C virus amino acid covariance networks can predict response to antiviral therapy in humans.Aurora R, Donlin MJ, Cannon…
Trasmissione dell’epatite B e C negli operatori sanitari non ospedalieri
Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998-2008. Thompson ND, Perz JF, Moorman AC, Holmberg SD.…
Livelli di transaminasi e rischio di sindrome metabolica, diabete e malattie cardiovascolari
Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease.Goessling W, Massaro JM, Vasan RS, D’Agostino RB Sr,…
Meta-analisi sulla performance dell’audit abbreviato
Meta-analysis: are 3 questions enough to detect unhealthy alcohol use? Kriston L, Hölzel L, Weiser AK, Berner MM, Härter M.…
Survey sull’epatite da farmaci in USA
Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.Chalasani N, Fontana RJ,…
Review sistematica sul trattamento percutaneo dell’HCC
Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies.Cho YK, Kim JK, Kim MY, Rhim H,…
Un nuovo marker per la NASH
Plasma Pentraxin3 is a Novel Marker for Nonalcoholic Steatohepatitis (NASH).Yoneda M, Uchiyama T, Kato S, Endo H, Fujita K, Yoneda…
Nuovo score per la stratificazione dei pazienti con epatite alcolica
A New Scoring System for Prognostic Stratification of Patients With Alcoholic Hepatitis . Marlene Dominguez, Diego Rincón, Juan G. Abraldes,…
Meta-analisi dul management dell’encefalopatia con rifaximina vs disacaridi non assorbibili
Rifaximin versus nonabsorbable disaccharides in the management of hepatic encephalopathy: a meta-analysis.Jiang Q, Jiang XH, Zheng MH, Jiang LM, Chen…
Terapia prolungata con PEG-IFN nell’epatite cronica da HCV
Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon.Di Bisceglie AM, Shiffman ML, Everson GT, Lindsay KL, Everhart JE,…
Pioglitazone nella NASH: un RCT
Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis.Aithal GP, Thomas JA, Kaye PV, Lawson A, Ryder SD,…
Review sulla terapia dell’HCC con sorafenib
Review article: pharmacological therapy of hepatocellular carcinoma with sorafenib and other oral agents.Chaparro M, González Moreno L, Trapero-Marugán M, Medina…
Review sistematica sulla fibrosi epatica
Systematic review: hepatic fibrosis: regression with therapy.Zois CD, Baltayiannis GH, Karayiannis P, Tsianos EV. Aliment Pharmacol Ther. 2008 Aug 30.…
Review sull’uso dei farmaci nei pazienti epatopatici
Review Article: The use of potentially hepatotoxic drugs in patients with liver disease.Gupta NK, Lewis JH. Aliment Pharmacol Ther. 2008…
Meta-analisi su LOLA ed enecfalopatia epatica
l-Ornithine-l-aspartate in the management of hepatic encephalopathy: A meta-analysis.Jiang Q, Jiang XH, Zheng MH, Chen YP. J Gastroenterol Hepatol. 2008…
